Last update:

Parkinson's & Movement disorders news

Parkinson's & Movement disorders

Machine learning helps define new subtypes of Parkinson's disease

Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson's disease based on the pace at which the disease progresses. In addition to having the potential to become an important ...

Neuroscience

Study reveals link between playing contact sports and parkinsonism in individuals with chronic traumatic encephalopathy

The largest study of CTE to date has found a new link between playing contact sports, chronic traumatic encephalopathy (CTE), and the development of a movement disorder known as parkinsonism.

Medical research

Protein droplets likely don't cause Parkinson's, study suggests

Liquid-liquid phase separation is not a precursor to formation of amyloid fibrils, a pathological hallmark of Parkinson's disease, shows a recent study. Rather, the formation of protein into liquid droplets may help to dissolve ...

Parkinson's & Movement disorders

Study reveals racial disparities in Huntington's disease diagnoses

Research led by UCLA Health reveals that Black patients with Huntington's disease in the U.S. and Canada received their diagnoses, on average, one year later compared to white patients after symptoms first appear.

Parkinson's & Movement disorders

Improving measurement of Parkinson's disease severity with AI

Despite recent advancements in the treatment of Parkinson's disease, it remains a challenge to accurately measure the progression of symptoms in this neurological disorder. While noticeable symptoms like tremors, stiffness ...

Parkinson's & Movement disorders

Could AI be the answer to early Parkinson's disease diagnoses?

Parkinson's disease is a significant health concern with profound impacts on individuals, the health care system and broader society. The current diagnosis model, which heavily relies on a medical professional interpreting ...

Neuroscience

Cracking the code for cerebellar movement disorders

The cerebellum is a region of the brain that helps us refine our movements and learn new motor skills. Patients and mouse models experience many kinds of abnormal movements when their cerebellum is damaged. They can have ...

Neuroscience

New cellular mechanisms in Parkinson's disease discovered

A pair of recent studies led by Joseph Mazzulli, Ph.D., associate professor in The Ken & Ruth Davee Department of Neurology's Division of Movement Disorders, have uncovered previously unknown cellular mechanisms involved ...

Parkinson's & Movement disorders

Brain connectivity on MRI predicts Parkinson's disease progression

The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson's disease, according to a study published today in Radiology, ...

Parkinson's & Movement disorders

Recognizing symptoms of Parkinson's disease

April is Parkinson's Disease Awareness Month, which make this a good time to learn about the symptoms of Parkinson's disease.

Parkinson's & Movement disorders

Improving prospects for people with Parkinson's

In an evolving journey toward understanding and supporting those living with Parkinson's disease, a new report offers fresh insights into the burden it places on those affected.

Medications

New drug may slow rapid progression of Parkinson's disease

Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...

Parkinson's & Movement disorders

New hypothesis emerges on Parkinson's disease's origins and spread

The nose or the gut? For the past two decades, the scientific community has debated the wellspring of the toxic proteins at the source of Parkinson's disease. In 2003, a German pathologist, Heiko Braak, MD, first proposed ...

Neuroscience

Stool transplant shows promise for Parkinson's disease

Parkinson's disease (PD) is a common neurodegenerative disease that affects millions worldwide. Now, a groundbreaking clinical study conducted by researchers at Ghent University Hospital, VIB, and Ghent University has demonstrated ...